GE HealthCare, founded in 1892, is a global leader in medical technology and digital solutions dedicated to advancing healthcare. Headquartered in Chicago, Illinois, the company has a rich heritage of innovation spanning more than a century, offering advanced diagnostic tools, comprehensive patient monitoring systems, and pharmaceutical diagnostics critical to modern medicine.

The company was originally part of General Electric but spun off as an independent entity on January 4, 2023, trading on the Nasdaq under the ticker symbol “GEHC.” This strategic move allows GE HealthCare the freedom to invest and innovate with a clear mission to improve precision care and create a future where healthcare has no limits.

Under the leadership of CEO Peter Arduini, GE HealthCare employs around 56,000 professionals globally who focus on delivering precise, personalized care by leveraging cutting-edge technologies. Their portfolio supports healthcare providers by improving diagnosis accuracy, treatment efficacy, and operational efficiency through integrated digital solutions.

GE HealthCare continues to build on its historic milestones, such as launching the first 4D ultrasound for women’s health and pioneering integrated hybrid infant incubator systems, maintaining its role at the forefront of medical innovation worldwide.

The company remains committed to partnering with healthcare providers to fulfill the greatest potential in healthcare, emphasizing groundbreaking innovation and patient-centric solutions to advance the future of medicine.